Chronic Rhinosinusitis Market is expected to hit USD 4.5 billion by 2030 | Major Companies - Lyra Therapeutics, Novartis, Medtronic plc, GlaxoSmithKline plc, AstraZeneca

AI Briefing

• – The Global Chronic Rhinosinusitis Market size reached USD 2.6 billion in 2022 and is expected to reach USD 4.5 billion by 2030, growing with a CAGR of 7.3% during the forecast period 2024-2031.
• – Key players such as Lyra Therapeutics, Novartis, Medtronic plc, GlaxoSmithKline plc, and AstraZeneca are major contributors to the market's growth.
• – The market is expected to be driven by increasing prevalence of CRS and growing demand for targeted treatments and innovative therapies.